Breve descripción
Cure Glomerulonephropathy (CureGN) es un estudio observacional multicéntrico de cinco años de duración de pacientes con enfermedad glomerular.
Médico del ensayo / Coordinador del estudio
Bridget Johnson
Trial is for people with
Primary focal segmental glomerulosclerosis (FSGS), minimal change disease (MCD), membranous nephropathy (MN), and IgA nephropathy ...
Study Goal
The CureGN project will study 2,400 children and adults with the following glomerular diseases: minimal change disease (MCD), focal ...
What is involved for the patient?
Participants' health will be monitored over 5 years. This may require extra visits to your doctor.